Author(s):
Hanna Fathima P, Sijo Pattam, Muhammed Harshad P, Muhammed Sajir K
Email(s):
hannafathimap4u@gmail.com
DOI:
10.52711/0974-360X.2026.00277 
Address:
Hanna Fathima P*, Sijo Pattam, Muhammed Harshad P, Muhammed Sajir K
Department of Pharmaceutics, KMCT National College of Pharmacy, KMCT Medical College Campus, Manassery, Mukkam, Calicut 673602, Kerala, India.
*Corresponding Author
Published In:
Volume - 19,
Issue - 4,
Year - 2026
ABSTRACT:
Nanococrystal technology has gained attention as an effective strategy to improve the solubility, dissolution rate, and bioavailability of drugs with poor water solubility. This advanced approach integrates the principles of crystal engineering with nanoscale particle size reduction, enhancing the physicochemical attributes and therapeutic efficacy of drugs. Nanococrystals are hybrid of cocrystals and nanocrystals, offering advantages of both the techniques. Cocrystal consist of an active pharmaceutical ingredient (API) and an appropriate coformer, held together by non-covalent forces. The nanoscale particle size significantly increases the surface area, promoting better wettability and faster dissolution. Additionally, nanococrystals exhibit advantages such as improved stability, potential for targeted drug delivery, and feasibility for large-scale manufacturing. This review delves into the fundamentals, preparation techniques, characterization methods, and pharmaceutical applications of nanococrystals. It also addresses the challenges associated with this technology and examines future directions, highlighting its role in addressing solubility and bioavailability challenges in drug development.
Cite this article:
Hanna Fathima P, Sijo Pattam, Muhammed Harshad P, Muhammed Sajir K. Advancing Pharmaceutical Performance: Insights Into Nano-Cocrystals for Enhanced Solubility and Drug Delivery. Research Journal of Pharmacy and Technology. 2026;19(4):1928-4. doi: 10.52711/0974-360X.2026.00277
Cite(Electronic):
Hanna Fathima P, Sijo Pattam, Muhammed Harshad P, Muhammed Sajir K. Advancing Pharmaceutical Performance: Insights Into Nano-Cocrystals for Enhanced Solubility and Drug Delivery. Research Journal of Pharmacy and Technology. 2026;19(4):1928-4. doi: 10.52711/0974-360X.2026.00277 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-4-66
REFERENCES:
1. Ammanage, A.; Rodriques, P.; Kempwade, A.; Hiremath, R. Formulation and Evaluation of Buccal Films of Piroxicam Co-Crystals. Future J. Pharm. Sci. 2020; 6(1). https://doi.org/10.1186/s43094-020-00033-1
2. Savjani, K. T.; Gajjar, A. K.; Savjani, J. K. Drug Solubility: Importance and Enhancement Techniques. ISRN Pharm. 2012; 2012, 1–10. https://doi.org/10.5402/2012/195727
3. Ibrahim, M. M.; El-Nabarawi, M.; El-Setouhy, D. A.; Fadlalla, M. A. Polymeric Surfactant-Based Etodolac Chewable Tablets: Formulation and In Vivo Evaluation. AAPS PharmSciTech. 2010; 11(4): 1730–1737. https://doi.org/10.1208/s12249-010-9548-z
4. Malviya, V.; Burange, P.; Thakur, Y.; Tawar, M. Enhancement of Solubility and Dissolution Rate of Atazanavir Sulfate by Nanocrystallization. Indian J. Pharm. Educ. Res. 2021, 55(3s), S672–S680. https://doi.org/10.5530/ijper.55.3s.174
5. Shewale, S.; Shete, A. S.; Doijad, R. C.; Kadam, S. S.; Patil, V. A.; Yadav, A. V. Formulation and Solid State Characterization of Nicotinamide-Based Co-Crystals of Fenofibrate. Indian J. Pharm. Sci. 2015, 77(3), 328. https://doi.org/10.4103/0250-474x.159669
6. Blagden, N.; De Matas, M.; Gavan, P. T.; York, P. Crystal Engineering of Active Pharmaceutical Ingredients to Improve Solubility and Dissolution Rates. Adv. Drug Deliv. Rev. 2007; 59(7): 617–630. https://doi.org/10.1016/j.addr.2007.05.011
7. Gurav, A. S.; Kulkarni, A. S. Efavirenz Cocrystals with Ascorbic Acid: A Strategy for Polymorphic Modification and Improvement of Dissolution Properties. Res. J. Pharm. Technol. 2024; 17: 213–221. https://doi.org/10.52711/0974-360x.2024.00034
8. Emami, S.; Siahi-Shadbad, M.; Adibkia, K.; Barzegar-Jalali, M. Recent Advances in Improving Oral Drug Bioavailability by Cocrystals. Bioimpacts. 2018; 8(4): 305–320. https://doi.org/10.15171/bi.2018.33
9. Buddhadev, S. S.; Garala, K. C. Pharmaceutical Cocrystals—A Review. Proceedings. 2021; 69(1): 14. https://doi.org/10.3390/proceedings2020062014
10. Yadav, S.; Agnihotri, J.; Parab, I. Co-Crystal: An Overview on the Novel Techniques for the Formation of CoCrystal and Its Potential Benefit in the Pharmaceutical Industry. Int. J. Pharm. Pharm. Res. 2022; 23(4): 345–370.
11. Jit, T.; Shil, D.; Dasgupta, R. K.; Mallick, S.; Mukherjee, S. Cocrystal: A Review on the Design and Preparation of Pharmaceutical Cocrystals. Asian J. Res. Pharm. Sci. 2023; 13(4): 296–302. https://doi.org/10.52711/2231-5659.2023.00050
12. Kumar, M. D. T.; Shree, D. M. A Review on Role of Cocrystals in Formulation Development of Insoluble Drugs. World J. Pharm. Res. 2023, 12, 546–565. https://www.wjpr.net
13. Samineni, R.; Chimakurthy, J.; Sumalatha, K.; Dharani, G.; Rachana, J.; Manasa, K., et al. Co-Crystals: A Review of Recent Trends in Co-Crystallization of BCS Class II Drugs. Res. J. Pharm. Technol. 2019; 12(7): 3117. https://doi.org/10.5958/0974-360x.2019.00527.4
14. Mehta, C. H.; Srinivas, P. P.; Sb, A.; Mahany, K. B. F.; Koteshwara, K.; Nayak, U. Y. Computational and Experimental Insights in Design and Development of Aceclofenac Co-Crystals. Res. J. Pharm. Technol. 2022; 15(8): 3709–3716. https://doi.org/10.52711/0974-360x.2022.00622
15. Bose, P.; Chandra, S.; Das, A.; Roy, T.; Paul, S.; Mukherjee, L. Enhancement of Solubility of an Oral Hypoglycaemic Drug, Glimepiride by the Technique Cocrystallisation. Int. J. Pharm. Sci. Res. 2021; 12(2): 1092–1098. https://doi.org/10.13040/ijpsr.0975-8232.12(2).1092-08
16. Jassim, Z. E.; Al-Kinani, K. K.; Alwan, Z. S. Preparation and Evaluation of Pharmaceutical Cocrystals for Solubility Enhancement of Dextromethorphan HBr. Int. J. Drug Deliv. Technol. 2021: 11(4).
17. Ahirrao, S. P.; Sonawane, M. P.; Bhambere, D. S.; Udavant, P. B.; Ahire, E. D.; Kanade, R., et al. Cocrystal Formulation: A Novel Approach to Enhance Solubility and Dissolution of Etodolac. Biosci. Biotechnol. Res. Asia 2022; 19(1): 111–119. https://doi.org/10.13005/bbra/2971
18. Thomas, J. E.; Nayak, U. Y.; Jagadish, P.; Koteshwara, K. Design and Characterization of Valsartan Co-Crystals to Improve Its Aqueous Solubility and Dissolution Behavior. Res. J. Pharm. Technol. 2017; 10(1): 26. https://doi.org/10.5958/0974-360x.2017.00007.5
19. Batool, F.; Ahmad, M.; Minhas, M.; Khalid, Q.; Idrees, H.; Khan, F. Use of Glutaric Acid to Improve the Solubility and Dissolution Profile of Glipizide through Pharmaceutical Cocrystallization. Acta Pol. Pharm. Drug Res. 2019; 76(1): 103–114. https://doi.org/10.32383/appdr/94246
20. Utami, D.; Nugrahani, I.; Ibrahim, S. Studies of Preparation, Characterization, and Solubility of Mefenamic Acid-Nicotinamide Co-Crystal Synthesized by Using Melt Crystallization Method. Asian J. Pharm. Clin. Res. 2017; 10(5): 135. https://doi.org/10.22159/ajpcr.2017.v10i5.15863
21. Machado, T. C.; Gelain, A. B.; Rosa, J.; Cardoso, S. G.; Caon, T. Cocrystallization as a Novel Approach to Enhance the Transdermal Administration of Meloxicam. Eur. J. Pharm. Sci. 2018; 123: 184–190. https://doi.org/10.1016/j.ejps.2018.07.038
22. Nikam, V. J.; Patil, S. B. Pharmaceutical Cocrystals of Nebivolol Hydrochloride with Enhanced Solubility. J. Cryst. Growth. 2020, 534, 125488. https://doi.org/10.1016/j.jcrysgro.2020.125488
23. Ther, A. V.; Bhongade, Y. M.; Sawkare, A. D. Pharmaceutical Cocrystal of Cilnidipine–Benzoic Acid (Design, Formulation, and Evaluation). Int. J. Pharm. Pharm. Res. 2020; 19(1): 739–754. https://www.ijppr.humanjournals.com
24. Albadri, A. A.; Jihad, M. I.; Radhi, Z. A. Preparation, Characterization, and In Vitro Evaluation of Tenoxicam–Paracetamol Cocrystal. Int. J. Drug Deliv. Technol. 2020; 10(4): 542–546.
25. Alatas, F.; Ratih, H.; Soewandhi, S. N. Enhancement of Solubility and Dissolution Rate of Telmisartan by Telmisartan–Oxalic Acid Co-Crystal Formation. Int. J. Pharm. Pharm. Sci. 2015; 7(3): 423–426.
26. Budiman, A.; Apriliani, A.; Qoriah, T.; Megantara, S. Glibenclamide–Nicotinamide Cocrystals Synthesized by the Solvent Evaporation Method to Enhance Solubility and Dissolution Rate of Glibenclamide. Int. J. Drug Deliv. Technol. 2019; 9(1): 21–26. https://doi.org/10.25258/ijddt.9.1.4
27. Narwade, S.; Bagad, D. Nanocrystals—Universal Approach for Poorly Hydrophilic Drug. Res. J. Pharm. Dosage Forms Technol. 2013; 5(5): 245–251.
28. Patel, S. R.; Shah, D. P. A Review on Nanocrystals Drug Delivery System. Res. J. Pharm. Technol. 2015; 8(5): 647. https://doi.org/10.5958/0974-360x.2015.00103.1
29. Xalxo, N.; Naha, A.; Dhoot, A.; Priya, J. Nanocrystals: A Newer Technological Advancement in Drug Delivery. Res. J. Pharm. Technol. 2018; 11(4): 1685. https://doi.org/10.5958/0974-360x.2018.00314.1
30. Gaikwad, N. A.; Pujari, A. S.; Mane, I. V.; Vambhurkar, G. B.; Honmane, P. P. Formulation and Characterization of Atorvastatin Nanocrystal Tablet. Asian J. Pharm. Technol. 2019; 9(2): 99. https://doi.org/10.5958/2231-5713.2019.00017.5
31. Malviya, V.; Burange, P.; Thakur, Y.; Tawar, M. Enhancement of Solubility and Dissolution Rate of Atazanavir Sulfate by Nanocrystallization. Indian J. Pharm. Educ. Res. 2021; 55(3s): S672–S680. https://doi.org/10.5530/ijper.55.3s.174
32. Vadhera, B.; Shah, S.; Dudhat, K.; Dhaval, D.; Singe, S.; Prajapati, B. G. Ketoconazole Nanocrystals Fortified Gel for Improved Transdermal Applications. Nanofabrication. 2024, 9.
33. Ochi, M.; Kawachi, T.; Toita, E.; Hashimoto, I.; Yuminoki, K.; Onoue, S., et al. Development of Nanocrystal Formulation of Meloxicam with Improved Dissolution and Pharmacokinetic Behaviors. Int. J. Pharm. 2014; 474(1–2): 151–156. https://doi.org/10.1016/j.ijpharm.2014.08.022
34. Sharma, A.; Jain, A. P.; Arora, S. Formulation and In Vitro Evaluation of Nanocrystal Formulation of Poorly Soluble Drugs. J. Drug Deliv. Ther. 2020, 9(4-s), 1183–1190. https://doi.org/10.22270/jddt.v9i4-s.3873
35. Özdemir, S.; Üner, B.; Karaküçük, A.; Çelik, B.; Sümer, E.; Taş, Ç. Nanoemulsions as a Promising Carrier for Topical Delivery of Etodolac: Formulation Development and Characterization. Pharmaceutics. 2023, 15(10), 2510. https://doi.org/10.3390/pharmaceutics15102510
36. More, A.; Bade, P.; Darekar, S. A Review of Pharmaceutical Nano-Cocrystal: A Novel Strategy to Improve the Chemical and Physical Properties for Poorly Water Soluble Drugs. J. Adv. Sci. Res. 2023, 14(2), 40–43. https://doi.org/10.55218/jasr.202314203
37. Liu, M.; Hong, C.; Li, G.; Ma, P.; Xie, Y. The Generation of Myricetin–Nicotinamide Nanococrystals by Top-Down and Bottom-Up Technologies. Nanotechnology. 2016, 27(39), 395601. https://doi.org/10.1088/0957-4484/27/39/395601
38. Thakor, P.; Yadav, B.; Modani, S.; Shastri, N. R. Preparation and Optimization of Nano-Sized Cocrystals Using a Quality by Design Approach. CrystEngComm. 2020, 22(13), 2304–2314. https://doi.org/10.1039/c9ce01930h
39. Tan, J.; Liu, J.; Ran, L. A Review of Pharmaceutical Nano-Cocrystals: A Novel Strategy to Improve the Chemical and Physical Properties for Poorly Soluble Drugs. Crystals. 2021; 11(5), 463. https://doi.org/10.3390/cryst11050463
40. Witika, B. A.; Smith, V. J.; Walker, R. B. Top-Down Synthesis of a Lamivudine–Zidovudine Nano Co-Crystal. Crystals. 2020, 11(1), 33. https://doi.org/10.3390/cryst11010033
41. Bhandari, J.; Kanswami, N.; Pk, L. L. Nano Co-Crystal Engineering Technique to Enhance the Solubility of Ezetimibe. J. Young Pharm. 2020, 12(2s), s10–s15. https://doi.org/10.5530/jyp.2020.12s.40
42. Hidayat, A. F.; Sofiyandini, L.; Darusman, F. Development and Characterization of Mefenamic Acid–Nicotinamide Nano-Cocrystal. Heliyon. 2023. https://doi.org/10.2139/ssrn.4556716
43. De Smet, L.; Saerens, L.; De Beer, T.; Carleer, R.; Adriaensens, P.; Van Bocxlaer, J., et al. Formulation of Itraconazole Nanococrystals and Evaluation of Their Bioavailability in Dogs. Eur. J. Pharm. Biopharm. 2014, 87(1), 107–113. https://doi.org/10.1016/j.ejpb.2013.12.016
44. Huang, Y.; Li, J. M.; Lai, Z. H.; Wu, J.; Lu, T. B.; Chen, J. M. Phenazopyridine–Phthalimide Nano-Cocrystal: Release Rate and Oral Bioavailability Enhancement. Eur. J. Pharm. Sci. 2017, 109, 581–586. https://doi.org/10.1016/j.ejps.2017.09.020
45. Nugrahani, I.; Auli, W. N. Diclofenac–Proline Nano-Co-Crystal Development, Characterization, In Vitro Dissolution and Diffusion Study. Heliyon. 2020, 6(9), e04864. https://doi.org/10.1016/j.heliyon.2020.e04864
46. Salem, A.; Takácsi-Nagy, A.; Nagy, S.; Hagymási, A.; Gősi, F.; Vörös-Horváth, B., et al. Synthesis and Characterization of Nano-Sized 4-Aminosalicylic Acid–Sulfamethazine Cocrystals. Pharmaceutics. 2021, 13(2), 277. https://doi.org/10.3390/pharmaceutics13020277
47. Karashima, M.; Kimoto, K.; Yamamoto, K.; Kojima, T.; Ikeda, Y. A Novel Solubilization Technique for Poorly Soluble Drugs through the Integration of Nanocrystal and Cocrystal Technologies. Eur. J. Pharm. Biopharm. 2016, 107, 142–150. https://doi.org/10.1016/j.ejpb.2016.07.006
48. Pi, J.; Wang, S.; Li, W.; Kebebe, D.; Zhang, Y.; Zhang, B., et al. A Nano-Cocrystal Strategy to Improve the Dissolution Rate and Oral Bioavailability of Baicalein. Asian J. Pharm. Sci. 2019; 14(2): 154–164. https://doi.org/10.1016/j.ajps.2018.04.009